TITLE

Pentamidine Oral Inhalation

PUB. DATE
February 2020
SOURCE
AHFS Consumer Medication Information;Feb2020, p1
SOURCE TYPE
Database
DOC. TYPE
Article
ABSTRACT
Pentamidine is an anti-infective agent that helps to treat or prevent pneumonia caused by the organism Pneumocystis carinii. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
ACCESSION #
78169964

 

Related Articles

  • Pneumocystis carinii pneumonia.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p26 

    Reports on the US Food and Drug Administration's approval on the marketing of a suspension form of atovaquone in the treatment of pneumocystis carinii pneumonia. Advantages and convenience; Dosage.

  • Pneumocystis carinii pneumonia prophylaxis reduces mortality, costs.  // Formulary;Sep95, Vol. 30 Issue 9, p544 

    Presents an abstract of the article `The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia,' by J.E. Gallant, S.M. McAvinue, R.D. Moore et al, which appeared in the 1995 issue of `Chest' periodical.

  • Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Blanchet, Kevin D. // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p116 

    Presents a dialogue on current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Prophylaxis and compliance; Treatment of mild PCP; Patient management issues.

  • PCP PREVENTION ALERT. Delaney, Martin // Advocate;11/19/91, Issue 590, p37 

    Reports on the medical alert received by physicians from the U.S. National Institutes of Health concerning the prevention of second bouts of Pneumocystis carinii pneumonia. Call for monthly treatments with aerosol pentamidine; Superiority of the oral use of two common antibiotics.

  • Prophylaxis Failure Is Associated with a Specific Pneumocystis carinii Genotype. Hauser, Philippe M.; Sudre, Philippe; Nahimana, Aimable; Francioli, Patrick // Clinical Infectious Diseases;10/1/2001, Vol. 33 Issue 7, p1080 

    To investigate the possible association between Pneumocystis carinii types and various clinical and demographic parameters, we used molecular typing to analyze 93 bronchoalveolar lavage specimens from patients with P. carinii pneumonia (PCP). Multivariate regression analysis revealed an...

  • Exposure of health care workers to pentamidine isethionate. Beach, J. R.; Campbell, M.; Andrews, D. J. // Occupational Medicine;1999, Vol. 49 Issue 4, p243 

    Pentamidine isethionate is currently used for the prophylaxis and treatment of Pneumocystis carinii pneumonia. Its use has been associated with a number of symptoms in staff administering treatment, and there are some additional concerns about possible adverse health effects of long term...

  • Avoiding the risk. Jesitus, John // Dermatology Times;Feb2013, Vol. 34 Issue 2, p27 

    The article explains the importance of considering pneumocystis pneumonia (PCP) prophylaxis in certain immunosuppressed patients, according to Doctor Amer N. Kalaaji, an associate professor of dermatology at the Mayo Clinic in Rochester, Minnesota. One study showed that the development of PCP...

  • RACE AND TREATMENT ACCESS.  // Advocate;6/28/94, Issue 658, p58 

    Reports on racial disparities in the administration of antiretroviral therapy and prophylactic treatment for Pneumocystis carinii pneumonia. Access to and standards of care.

  • Improved Treatment For Pneumocystis. Helquist, Michael // Advocate;10/13/87, Issue 483, p23 

    Reports on the efficacy of aerosol pentamidine against pneumocystis carinii pneumonia in persons with AIDS. Absence of side effects; Reduction in average hospital stay.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics